FMP

FMP

Enter

DAWN - Day One Biopharmaceu...

Financial Summary of Day One Biopharmaceuticals, Inc.(DAWN), Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercia

photo-url-https://financialmodelingprep.com/image-stock/DAWN.png

Day One Biopharmaceuticals, Inc.

DAWN

NASDAQ

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.

15.21 USD

0.11 (0.723%)

About

ceo

Dr. Jeremy Bender M.B.A., Ph.D.

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.

CIK

0001845337

ISIN

US23954D1090

CUSIP

23954D109

Address

395 Oyster Point Boulevard

Phone

650 484 0899

Country

US

Employee

174

IPO Date

May 27, 2021

Summary

CIK

0001845337

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

23954D109

ISIN

US23954D1090

Country

US

Price

15.21

Beta

-1.51

Volume Avg.

1.21M

Market Cap

1.33B

Shares

-

52-Week

9.67-18.07

DCF

2.89

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-6.08

P/B

-

Website

https://dayonebio.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest DAWN News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep